Celularity Inc. Stock-Based Compensation
Celularity Inc. (CELU) reported Stock-Based Compensation of $471.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2025-11-14
- Celularity Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $471.00K.
- Celularity Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $108.00K.
- Celularity Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $0.00.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2025-09-30 | $471.00K 10-Q · filed 2025-11-14 | $579.00K derived: sum of 2 quarters · filed 2025-11-14 | $788.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $108.00K 10-Q · filed 2025-08-29 | $108.00K 10-Q · filed 2025-08-29 | ||
| 2023-12-31 | $0.00 10-K · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |